The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison
- Mateos, M.-V.
- San-Miguel, J.
- Goldschmidt, H.
- Sonneveld, P.
- Dimopoulos, M.A.
- Heeg, B.
- Hashim, M.
- Deraedt, W.
- Hu, P.
- Lam, A.
- He, J.
ISSN: 1029-2403, 1042-8194
Ano de publicación: 2020
Volume: 61
Número: 3
Páxinas: 680-690
Tipo: Artigo